Chemotherapy of extensive large cell and adenocarcinoma of the lung. A randomized trial in 210 patients

R. G. Vincent, C. R. Mehta, R. D. Tucker, C. F. Mountain, M. Cohen, H. E. Wilson, Charles Vogel

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Two hundred ten patients with advanced adenocarcinoma of the lung were entered into a two-arm randomized trail. Cytoxan + CCNU + methotrexate was compared to Adriamycin and procarbazine. The tumor response to CCM was significantly higher than the tumor response to Adriamycin and procarbazine. No significance existed between the two treatments with respect to survival. Initial performance status, weight loss prior to therapy, and response to therapy were all found to be significant prognostic factors. Median survival time relative to responders in both treatment groups was 31.7 weeks and 15.8 weeks for non-responders.

Original languageEnglish
Pages (from-to)256-260
Number of pages5
JournalCancer
Volume46
Issue number2
StatePublished - Sep 19 1980
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Vincent, R. G., Mehta, C. R., Tucker, R. D., Mountain, C. F., Cohen, M., Wilson, H. E., & Vogel, C. (1980). Chemotherapy of extensive large cell and adenocarcinoma of the lung. A randomized trial in 210 patients. Cancer, 46(2), 256-260.